Takuya Okada

1.3k total citations
72 papers, 827 citations indexed

About

Takuya Okada is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Takuya Okada has authored 72 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 24 papers in Organic Chemistry and 11 papers in Physiology. Recurrent topics in Takuya Okada's work include Synthetic Organic Chemistry Methods (8 papers), Neuropeptides and Animal Physiology (7 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers). Takuya Okada is often cited by papers focused on Synthetic Organic Chemistry Methods (8 papers), Neuropeptides and Animal Physiology (7 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers). Takuya Okada collaborates with scholars based in Japan, United States and United Kingdom. Takuya Okada's co-authors include Yasufumi Ohfune, Kazuhiko Sakaguchi, Naoki Toyooka, Tetsuro Shinada, Norihiro Tada, Masahito Ochiai, Takeshi Yamada, Kazunori Miyamoto, Vadim A. Soloshonok and Hisanori Ueki and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Takuya Okada

67 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuya Okada Japan 17 390 319 76 73 69 72 827
A. Michael Crider United States 17 542 1.4× 378 1.2× 70 0.9× 155 2.1× 105 1.5× 55 1.0k
Violetta Constantinou‐Kokotou Greece 20 544 1.4× 848 2.7× 70 0.9× 62 0.8× 53 0.8× 70 1.3k
Kyu Yang Yi South Korea 19 440 1.1× 489 1.5× 38 0.5× 86 1.2× 86 1.2× 74 1.1k
Frank Kayser United States 19 692 1.8× 725 2.3× 65 0.9× 140 1.9× 117 1.7× 33 1.4k
Satyamaheshwar Peddibhotla United States 15 755 1.9× 498 1.6× 46 0.6× 227 3.1× 71 1.0× 30 1.3k
Keizo Ito Japan 15 199 0.5× 297 0.9× 85 1.1× 69 0.9× 47 0.7× 72 821
Michele Leuenberger Switzerland 12 216 0.6× 374 1.2× 34 0.4× 100 1.4× 70 1.0× 16 739
Antonio Giordani Italy 21 434 1.1× 303 0.9× 67 0.9× 105 1.4× 41 0.6× 37 900
Narihiro Toda Japan 16 598 1.5× 345 1.1× 44 0.6× 46 0.6× 87 1.3× 24 884
Nuria Tamayo United States 22 512 1.3× 376 1.2× 122 1.6× 94 1.3× 59 0.9× 31 1.2k

Countries citing papers authored by Takuya Okada

Since Specialization
Citations

This map shows the geographic impact of Takuya Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Okada more than expected).

Fields of papers citing papers by Takuya Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Okada. The network helps show where Takuya Okada may publish in the future.

Co-authorship network of co-authors of Takuya Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Okada. A scholar is included among the top collaborators of Takuya Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Okada. Takuya Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shintani, Yusuke, Atsuko Hayata‐Takano, Ichiro Takasaki, et al.. (2025). Rapid and long-lasting antidepressant-like effects of the pituitary adenylate cyclase-activating polypeptide receptor antagonist PA-915 in chronic stress mouse models. Molecular Psychiatry. 31(2). 1014–1026.
2.
Nash, Robert J., et al.. (2024). Synthesis of 8-epi-l-swainsonine, related C6 alkylated derivatives and their α-l-rhamnosidase inhibition. Tetrahedron Letters. 139. 155008–155008. 1 indexed citations
3.
Kobayashi, Eiji, Chihiro Motozono, Hiroshi Hamana, et al.. (2024). Characterization of Tumor-Infiltrating Lymphocyte-Derived Atypical TCRs Recognizing Breast Cancer in an MR1-Dependent Manner. Cells. 13(20). 1711–1711. 3 indexed citations
4.
Okada, Takuya, et al.. (2024). Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluations. Journal of Medicinal Chemistry. 67(16). 14313–14328. 2 indexed citations
5.
Okada, Takuya, Ryusuke Sawada, Yoshihiro Yamanishi, et al.. (2023). Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 93. 129438–129438. 2 indexed citations
6.
Okada, Takuya, et al.. (2023). Concise Total Synthesis of rac‐Betuphenone F. European Journal of Organic Chemistry. 26(12). 3 indexed citations
7.
Yokoyama, Takeshi, Mineyuki Mizuguchi, Yuko Nabeshima, et al.. (2023). Rafoxanide, a salicylanilide anthelmintic, interacts with human plasma protein transthyretin. FEBS Journal. 290(21). 5158–5170. 2 indexed citations
8.
Tsuneki, Hiroshi, Masanori Sugiyama, Hisakatsu Ito, et al.. (2023). Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice. European Journal of Pharmacology. 961. 176190–176190. 1 indexed citations
9.
Baba, Hayato, Tomoyuki Okumura, Johji Imura, et al.. (2023). Nicolaioidesin C: An Antiausterity Agent Shows Promising Antitumor Activity in a Pancreatic Cancer Xenograft Mouse Model. Journal of Natural Products. 86(6). 1402–1410. 6 indexed citations
10.
Kato, Atsushi, Izumi Nakagome, Nobutada Tanaka, et al.. (2023). Design and Pharmacological Chaperone Effects of N-(4′-Phenylbutyl)-DAB Derivatives Targeting the Lipophilic Pocket of Lysosomal Acid α-Glucosidase. Journal of Medicinal Chemistry. 66(13). 9023–9039. 5 indexed citations
11.
Mizuguchi, Mineyuki, et al.. (2023). Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis. Bioorganic & Medicinal Chemistry. 90. 117370–117370. 7 indexed citations
12.
Takasaki, Ichiro, Ai Watanabe, Takuya Okada, et al.. (2022). Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist. European Journal of Medicinal Chemistry. 231. 114160–114160. 10 indexed citations
13.
Okada, Takuya, et al.. (2022). Design and synthesis of novel pipernonaline derivatives as anti-austerity agents against human pancreatic cancer PANC-1 cells. Bioorganic & Medicinal Chemistry. 71. 116963–116963. 6 indexed citations
14.
Sun, Sijia, Min Jo Kim, Dya Fita Dibwe, et al.. (2021). Anti-Austerity Activity of Thai Medicinal Plants: Chemical Constituents and Anti-Pancreatic Cancer Activities of Kaempferia parviflora. Plants. 10(2). 229–229. 17 indexed citations
15.
Yokoyama, Takeshi, et al.. (2021). Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis. Bioorganic & Medicinal Chemistry. 44. 116292–116292. 6 indexed citations
16.
Tsubota, Maho, Kaoru Yamaguchi, Junichi Tanaka, et al.. (2020). Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H2S/Cav3.2 Signaling in Mice. Cells. 9(8). 1748–1748. 38 indexed citations
17.
Noso, Shinsuke, Naru Babaya, Yoshihisa Hiromine, et al.. (2019). Contribution of Asian Haplotype of KCNJ18 to Susceptibility to and Ethnic Differences in Thyrotoxic Periodic Paralysis. The Journal of Clinical Endocrinology & Metabolism. 104(12). 6338–6344. 5 indexed citations
18.
Okada, Takuya, Fumiko Sekiguchi, Maho Tsubota, et al.. (2018). Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers. Bioorganic & Medicinal Chemistry. 26(15). 4410–4427. 16 indexed citations
19.
Sekiguchi, Fumiko, Maho Tsubota, S. Yoshida, et al.. (2018). Critical role of Cav3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice. Toxicology. 413. 33–39. 43 indexed citations
20.
Fukuda, Kazuto, Takuya Okada, Ayumu Hirata, et al.. (2015). Usefulness of ultrasonographic estimation of preperitoneal and subcutaneous fat thickness in the diagnosis of nonalcoholic fatty liver disease in diabetic patients. Journal of Medical Ultrasonics. 42(3). 357–363. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026